Polycystic Ovary Syndrome in Adolescence and Type 2 Diabetes

    November 2014 in “ Current Diabetes Reports ”
    Anne-Marie Carreau, Jean-Patrice Baillargeon
    Image of study
    TLDR Girls with PCOS during adolescence have a higher risk of developing type 2 diabetes, and early treatment can help manage this risk.
    The document from 2014 examines the link between polycystic ovary syndrome (PCOS) in adolescents and the increased risk of developing type 2 diabetes (T2DM). It outlines the complexity of diagnosing PCOS during puberty due to overlapping symptoms but stresses the importance of early detection to manage long-term metabolic risks. The prevalence of PCOS is lower in adolescents than adults, with obesity exacerbating the condition. Insulin resistance is a key factor in PCOS pathogenesis, and insulin sensitization can improve symptoms. Lipotoxicity and adipose tissue dysfunction are also implicated in PCOS and T2DM development. Early life factors and genetic predisposition contribute to PCOS, with interventions like metformin showing promise in reducing the risk. The document also discusses the high prevalence of metabolic syndrome (MS) and impaired glucose tolerance (IGT) in obese adolescents with PCOS, and the need for targeted treatment, including lifestyle changes, oral contraceptives, insulin sensitizers, and anti-androgens. An open-label trial with 34 adolescents showed that combination therapy with low doses of pioglitazone, metformin, and flutamide was more effective than oral contraceptives alone in treating PCOS and improving cardiovascular risk factors. The document concludes with the recommendation for screening and prevention of T2DM in adolescent girls with PCOS, considering the potential adverse effects of oral contraceptives on glucose tolerance and the benefits of insulin sensitizers.
    Discuss this study in the Community →

    Research cited in this study

    8 / 8 results

    Related Community Posts Join

    6 / 97 results

      community Female, 30, PCOS diagnosis, MPB Norwood 2. Endo refuses to give anything other than Spironolactone. Feel like I’m at my wit’s end here.

      in Female  53 upvotes 1 year ago
      A 30-year-old female with PCOS and male pattern baldness is frustrated with her endocrinologist's recommendation of only Spironolactone and minoxidil, feeling that dutasteride, finasteride, and progesterone would be more effective. Other users suggest various online sources for treatments, warn against self-medicating due to potential risks, and recommend seeking a specialized endocrinologist or considering additional treatments like Inositol, Berberine, and dermaneedling.
      Diffuse hair loss and scalp biopsies

      community Diffuse hair loss and scalp biopsies

      in Research  692 upvotes 4 months ago
      Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.

      community Horrible news, Stemson Therapeutics has shut down

      in Technology  193 upvotes 1 week ago
      Stemson Therapeutics has shut down, disappointing those seeking a hair loss cure. Current treatments like minoxidil, finasteride, and dutasteride are discussed, with some users experiencing side effects and exploring alternatives like PP405.

      community C’est terrible - at my wits end

      in Female  449 upvotes 1 year ago
      A 29-year-old woman is experiencing gradual hair thinning since age 15, suspects Androgenic Alopecia, and has tried 5% minoxidil with little success. She has purchased various hair loss treatments including minoxidil, dutasteride, finasteride, and spironolactone, but is cautious about starting them due to potential interactions with her ADHD medication.

    Similar Research

    5 / 1000+ results